Trials / Conditions / Antineoplastics Toxicity
Antineoplastics Toxicity
3 registered clinical trials studyying Antineoplastics Toxicity — 3 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | The STOP-MED CTRCD Trial NCT06183437 | Dinesh Thavendiranathan | Phase 4 |
| Recruiting | Stage II-IIIa Urothelial Cancer Randomizing Pre-operative Nivolumab With or Without Relatlimab NCT06237920 | The Netherlands Cancer Institute | Phase 2 |
| Recruiting | Immune Checkpoint Inhibitors Nephrotoxicity NCT04902846 | R. Laura Vicente Vicente | — |